Allianz Research Institute

Help in development of future medicines

We work closely with key opinion leaders, scientists and different pharmaceutical and biotech companies to bring medicine to the world.

Gain access to new medical treatment

Clinical research trials gives participants the opportunity to gain access to our renown physicians and healthcare team as well innovative medicines at the leading edge of pharmaceutical evolution. We are not only providing more patients with access to innovative care options, we have been transforming the healthcare industry in asthma and COPD therapeutic areas for 15 years. We are taking that knowledge forward to other therapeutic areas for our future

Receive compensation for time & travel

The financial benefits of participation typically will cover your time and travel and won’t replace the need for a regular job, The knowledge in contributing to the growth of medical therapy and sporty will be greatly appreciated.

A world of health services

Allianz Research Institute and its affiliate partners work closely with Clinical Research Organizations and Sponsors to help improve research subject diversity. We are committed to engaging diverse and underrepresented communities throughout Southern California.Under the leadership of Dr. Kareem Ahmad, our team is able to serve patients from a wide range of cultural and linguistic backgrounds, with fluency in Vietnamese, Urdu/Hindi, Punjabi, and Spanish.
Our staff also includes team members fluent in Vietnamese and Spanish, helping us better communicate with and support the communities we serve. We also partner with local free clinics and community-based organizations that care for underserved populations, allowing us to expand access to clinical research opportunities for patients who are often underrepresented in medical studies.

Our future goals:

Currently we are building the following therapeutic area ecosystem as well as, developing our Phase 1 capacity:

Interstitial Lung Disease
Cardiovascular Disease
Cancer screening
Obesity

Bronchiectasis
Infectious disease
Diabetes
Alzheimer

A World of Health Services

COPD STUDIES

Since COPD is progressive, it is important to identify and treat patients at early stages in order to prevent further deterioration. Combination inhalers such as Breztri and Trelegy and improved breathlessness and reduced exacerbation. Biologics will play a significant role in controlling the disease and potentially reverse the disease. Through clinical trials we now see Dupixent or dupilumab reducing exacerbation and increase lung function an additional 94 ml. Other biologics that block IL-5R, TSLP, OX-40L and IL-33 may help control inflammation of COPD.
‍

ASTHMA STUDIES

Asthma is a chronic inflammatory disease that causes airway inflammation and airway remodeling or scaring. Clinical research helps us understand how the disease is caused, how it develops and how it is best treated. Stopping the inflammation and slowing the progression of remodeling will be the key in treating this disease. Like COPD, several different biologics may play a role in blocking the inflammation and help reverse the disease. Take the disease into your own hands and learn more how to control this disease. Contact us for more information on how to participate.

Active Studies

Please call or email us for more information in regards to the study and compensation amount

Asthma Trials

1) Bellanos
2) Stride
3) Acadia

COPD

1) UPB-06
2) Tharros

Alzheimer

We are expanding our services to cover Alzheimer

Gastrointestinal disease

We are expanding our services to cover inflammatory bowel disease such as Ulcerative

We are certified researchers committed to excellence.